Peter Jorth Ph.D.

Dr. Peter Jorth obtained his Ph.D. in Microbiology from the University of Texas at Austin. His NIH-supported predoctoral research focused on community dynamics of the oral microbiota during the transition from health to periodontal disease. During his doctoral studies Dr. Jorth became a leading expert in applying next-generation sequencing to study polymicrobial interaction in the human microbiome. In addition to receiving an NIH National Research Service Award supporting his doctoral studies, he also received several awards recognizing his research accomplishments, and a student-nominated award for excellence in teaching from the College of Natural Sciences. Currently, Dr. Jorth is a Cystic Fibrosis Foundation Postdoctoral Fellow at the University of Washington School of Medicine. As a fellow in Dr. Pradeep K. Singh's group, Dr. Jorth is studying Pseudomonas aeruginosa diversification during CF pulmonary infections. Dr. Jorth has authored 10 publications and 1 book chapter during his early career. He is a member of the American Society for Microbiology. Dr. Jorth is currently interested in how P. aeruginosa diversifies during CF infection, and how bacterial diversification impacts disease progression and recalcitrance to therapeutic intervention. In addition, he is examining how and why bacterial infections persist after CFTR correction with ivacaftor.